Stocks Health care AVNS
NYSE · Health careAvanos Medical, Inc. (AVNS)
Avanos Medical, Inc. brought in $715.9M of revenue over the twelve months to March 31, 2026, up 3.9% from a year earlier. It posted a net loss of $74.4M. Operating cash flow minus capital spending left $43.1M of free cash flow in fiscal 2025. At March 31, 2026 it held $65.6M in cash against $87.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 5, 2026.
Watch AVNS in 60 secondsWhat Avanos Medical, Inc. does
Avanos Medical, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker AVNS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $701.2M | -$72.9M | -$1.57 | $43.1M |
| 2024 | $687.8M | -$392.1M | -$8.53 | $82.9M |
| 2023 | $673.3M | -$61.8M | -$1.32 | $14.6M |
| 2022 | $684.1M | $50.5M | $1.07 | $71.6M |
| 2021 | $587M | $6.3M | $0.13 | $66.3M |
| 2020 | $714.8M | -$29M | -$0.61 | -$22.7M |
Full financial statements: income, balance sheet and cash flow
Where AVNS ranks in Health care
Latest SEC filings
What Avanos Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 6, 2026Deregistration 15-12G
- July 31, 2026Form S-8 POS filing S-8 POS
- July 31, 2026Passive stake (5% or more) SCHEDULE 13G
- July 30, 2026
- July 27, 2026Delisting notice 25-NSE
- July 22, 2026
- July 15, 2026Additional proxy material DEFA14A
- July 15, 2026Other event 8-K
- July 2, 2026Additional proxy material DEFA14A
- July 2, 2026
What is AVNS worth? A DCF from its reported cash flow
Insider trades
What the people running Avanos Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 15 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 27, 2026 | Blackford GaryDirector | Other changeindirect | 40,000 | $1M |
| July 27, 2026 | Blackford GaryDirector | Other change | 79,590 | $2M |
| July 27, 2026 | Egbuonu-Davis LisaDirector | Other change | 13,811 | $345.3K |
| July 27, 2026 | Franchini Indrani LallDirector | Other change | 4,817 | $120.4K |
| July 27, 2026 | Oleary Patrick JDirector | Other change | 54,640 | $1.4M |
| July 27, 2026 | Shimer Julie AnnDirector | Other change | 50,090 | $1.3M |
| July 27, 2026 | Pacitti DavidChief Executive Officer | Other change | 322,194 | $8.1M |
| July 27, 2026 | Pacitti DavidChief Executive Officer | Received as pay | 444,730 | - |
| July 27, 2026 | Pacitti DavidChief Executive Officer | Other change | 444,730 | $11.1M |
| July 27, 2026 | Galovan Scott MichaelSVP, Chief Financial Officer | Other change | 135,596 | $3.4M |
| July 27, 2026 | Galovan Scott MichaelSVP, Chief Financial Officer | Received as pay | 96,121 | - |
| July 27, 2026 | Galovan Scott MichaelSVP, Chief Financial Officer | Other change | 96,121 | $2.4M |
| July 27, 2026 | Delgado SigfridoSVP, Operations | Other change | 55,741 | $1.4M |
| July 27, 2026 | Delgado SigfridoSVP, Operations | Received as pay | 54,886 | - |
| July 27, 2026 | Delgado SigfridoSVP, Operations | Other change | 54,886 | $1.4M |
Who owns AVNS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 5% | July 31, 2026 |
Largest institutional holders
Insiders
Questions about AVNS
What does Avanos Medical, Inc. do?
Avanos Medical, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker AVNS.
Is Avanos Medical, Inc. profitable?
No. Over the twelve months to March 31, 2026 it reported a net loss of $74.4M on revenue of $715.9M.
How much revenue does Avanos Medical, Inc. make?
Over the twelve months to March 31, 2026 Avanos Medical, Inc. reported revenue of $715.9M. That is 3.9% more than a year earlier.
When did Avanos Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 5, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the deregistration from August 6, 2026.
Similar companies
Compare AVNS with
Follow AVNS
Get an email when Avanos Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow AVNS: get an email when it filesWhere the numbers come from
Financial figures are the values Avanos Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.